171 related articles for article (PubMed ID: 36254139)
21. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
[TBL] [Abstract][Full Text] [Related]
22. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
23. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.
Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z
BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940
[TBL] [Abstract][Full Text] [Related]
24. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
[TBL] [Abstract][Full Text] [Related]
25. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
Front Immunol; 2022; 13():959967. PubMed ID: 36177002
[TBL] [Abstract][Full Text] [Related]
26. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
27. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
Li X; Wen D; Li X; Yao C; Chong W; Chen H
Front Immunol; 2020; 11():1678. PubMed ID: 33013820
[TBL] [Abstract][Full Text] [Related]
28. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
29. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
Zhang X; Wu Z; Ma K
BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
[TBL] [Abstract][Full Text] [Related]
30. Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system.
Haitina T; Lindblom J; Renström T; Fredriksson R
Genomics; 2006 Dec; 88(6):779-790. PubMed ID: 16949250
[TBL] [Abstract][Full Text] [Related]
31. Identification and Validation of the lncRNA BACE1-AS as Immune-Related Influencing Factor in Tumorigenesis following Pan-Carcinoma Analysis.
Wang M; Chen D; Xu Y; Qiu M; Jiang X; Xiong Z
J Immunol Res; 2021; 2021():1589864. PubMed ID: 34926701
[TBL] [Abstract][Full Text] [Related]
32. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of high YY1AP1 and PCNA expression in colon adenocarcinoma.
Ho YJ; Lin YM; Huang YC; Shi B; Yeh KT; Gong Z; Lu JW
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):173-180. PubMed ID: 29037809
[TBL] [Abstract][Full Text] [Related]
34. Alternative splicing implicated in immunity and prognosis of colon adenocarcinoma.
Wu Z; Chen H; Liang Y; Luo W; Deng F; Zeng F
Int Immunopharmacol; 2020 Dec; 89(Pt B):107075. PubMed ID: 33099068
[TBL] [Abstract][Full Text] [Related]
35. Identification of prognostic candidate signatures by systematically revealing transcriptome characteristics in lung adenocarcinoma with differing tumor microenvironment immune phenotypes.
Chen Q; Ma J; Wang X; Zhu X
Aging (Albany NY); 2022 Jun; 14(11):4786-4818. PubMed ID: 35675043
[TBL] [Abstract][Full Text] [Related]
36. A Study on Immune Cell Infiltration in Lung Adenocarcinoma.
Sun B; Zhao H
Comb Chem High Throughput Screen; 2022; 25(12):2082-2088. PubMed ID: 35189796
[TBL] [Abstract][Full Text] [Related]
37. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
38. Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer.
Liu J; Yi J; Zhang Z; Cao D; Li L; Yao Y
Aging (Albany NY); 2021 Jun; 13(12):16513-16526. PubMed ID: 34157681
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Molecular Analyses of an SLC Family-Based Model in Stomach Adenocarcinoma.
Yu T; Yu SK; Lu KH
Pathol Oncol Res; 2022; 28():1610610. PubMed ID: 36313898
[No Abstract] [Full Text] [Related]
40. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma.
Wu S; Gong Y; Chen J; Zhao X; Qing H; Dong Y; Li S; Li J; Wang Z
Biol Direct; 2022 Jul; 17(1):19. PubMed ID: 35902970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
